Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We assessed the impact of body mass index (BMI) on pathological complete response (pCR), disease-free (DFS), and overall survival (OS), according to BC subtypes in patients with primary BC treated with neoadjuvant...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 February 2015
|
| In: |
Breast cancer research and treatment
Year: 2015, Jahrgang: 150, Heft: 1, Pages: 127-139 |
| ISSN: | 1573-7217 |
| DOI: | 10.1007/s10549-015-3287-5 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s10549-015-3287-5 Verlag, Volltext: https://link.springer.com/article/10.1007/s10549-015-3287-5 Verlag, Abstract, Volltext: http://link.springer.com/article/10.1007/s10549-015-3287-5 
|
| Verfasserangaben: | Caterina Fontanella, Bianca Lederer, Stephan Gade, Mieke Vanoppen, Jens Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, Bernd Gerber, Claus Hanusch, Jörn Hilfrich, Jens Huober, Andreas Schneeweiss, Stefan Paepke, Christian Jackisch, Keyur Mehta, Valentina Nekljudova, Michael Untch, Patrick Neven, Gunter von Minckwitz, Sibylle Loibl |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 840616546 | ||
| 003 | DE-627 | ||
| 005 | 20250223010352.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 151123s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10549-015-3287-5 |2 doi | |
| 035 | |a (DE-627)840616546 | ||
| 035 | |a (DE-576)9840616544 | ||
| 035 | |a (DE-599)GBV840616546 | ||
| 035 | |a (OCoLC)1340145230 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fontanella, Caterina |e VerfasserIn |0 (DE-588)1136378642 |0 (DE-627)892779144 |0 (DE-576)490477097 |4 aut | |
| 245 | 1 | 0 | |a Impact of body mass index on neoadjuvant treatment outcome |b a pooled analysis of eight prospective neoadjuvant breast cancer trials |c Caterina Fontanella, Bianca Lederer, Stephan Gade, Mieke Vanoppen, Jens Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, Bernd Gerber, Claus Hanusch, Jörn Hilfrich, Jens Huober, Andreas Schneeweiss, Stefan Paepke, Christian Jackisch, Keyur Mehta, Valentina Nekljudova, Michael Untch, Patrick Neven, Gunter von Minckwitz, Sibylle Loibl |
| 264 | 1 | |c 13 February 2015 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Obesity is associated with an increased risk of breast cancer (BC) and poorer outcome. We assessed the impact of body mass index (BMI) on pathological complete response (pCR), disease-free (DFS), and overall survival (OS), according to BC subtypes in patients with primary BC treated with neoadjuvant chemotherapy. 8,872 patients with primary BC from eight neoadjuvant trials were categorized according to BMI: underweight (<18.5 kg/m2), normal weight (18.5 to <25 kg/m2), overweight (25 to <30 kg/m2), obese (30 to <40 kg/m2), and very obese (≥40 kg/m2). BC subtypes were defined as luminal-like (ER/PgR-positive and HER2-negative), HER2/luminal (ER/PgR-positive and HER2-positive), HER2-like (ER/PgR-negative and HER2-positive), and triple-negative (TNBC; ER/PgR- and HER2-negative). pCR rate was higher in normal weight patients compared with all other BMI groups (P = 0.003). Mean DFS and OS were shorter in obese (87.3 months, P = 0.014 and 94.9 months, P = 0.001, respectively) and very obese (66.6 months, P < 0.001 and 75.3 months, P < 0.001, respectively) compared with normal weight patients (91.5 and 98.8 months, respectively) which was confirmed by subpopulation treatment effect pattern plot analyses and was consistent in luminal-like and TNBC. No interaction was observed between BMI and pCR. Normal weight patients experienced less non-hematological adverse events (P = 0.002) and were more likely to receive full taxane doses (P < 0.001) compared with all other BMI groups. In multivariable analysis, the dose of taxanes was predictive for pCR (P < 0.001). Higher BMI was associated with lower pCR and a detrimental impact on survival. Normal weight patients had the best compliance to chemotherapy and received the highest taxane doses, which seems to be related with treatment outcomes. | ||
| 700 | 1 | |a Lederer, Bianca |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gade, Stephan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vanoppen, Mieke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Blohmer, Jens-Uwe |d 1962- |e VerfasserIn |0 (DE-588)122376641 |0 (DE-627)081907958 |0 (DE-576)293244227 |4 aut | |
| 700 | 1 | |a Costa, Serban Dan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Denkert, Carsten |d 1969- |e VerfasserIn |0 (DE-588)118129929 |0 (DE-627)079261124 |0 (DE-576)291730604 |4 aut | |
| 700 | 1 | |a Eidtmann, Holger |d 1954- |e VerfasserIn |0 (DE-588)172619130 |0 (DE-627)673654575 |0 (DE-576)133478335 |4 aut | |
| 700 | 1 | |a Gerber, Bernd |d 1957- |e VerfasserIn |0 (DE-588)136713238 |0 (DE-627)585337608 |0 (DE-576)301234620 |4 aut | |
| 700 | 1 | |a Hanusch, Claus Alexander |d 1972- |e VerfasserIn |0 (DE-588)130827525 |0 (DE-627)506018563 |0 (DE-576)298362279 |4 aut | |
| 700 | 1 | |8 1\p |a Hilfrich, Jörn |d 1941- |e VerfasserIn |0 (DE-588)1271308592 |0 (DE-627)1820077217 |4 aut | |
| 700 | 1 | |a Huober, Jens |e VerfasserIn |0 (DE-588)1059154676 |0 (DE-627)798048239 |0 (DE-576)415183898 |4 aut | |
| 700 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 700 | 1 | |a Paepke, Stefan |d 1964- |e VerfasserIn |0 (DE-588)17293639X |0 (DE-627)697863484 |0 (DE-576)133790584 |4 aut | |
| 700 | 1 | |a Jackisch, Christian |d 1960- |e VerfasserIn |0 (DE-588)1024193160 |0 (DE-627)71932730X |0 (DE-576)368124908 |4 aut | |
| 700 | 1 | |a Mehta, Keyur |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nekljudova, Valentina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Untch, Michael |e VerfasserIn |0 (DE-588)134268083 |0 (DE-627)566077914 |0 (DE-576)300413572 |4 aut | |
| 700 | 1 | |a Neven, Patrick |e VerfasserIn |4 aut | |
| 700 | 1 | |a Minckwitz, Gunter von |d 1964- |e VerfasserIn |0 (DE-588)172260035 |0 (DE-627)673296962 |0 (DE-576)133128202 |4 aut | |
| 700 | 1 | |a Loibl, Sibylle |e VerfasserIn |0 (DE-588)12433024X |0 (DE-627)085790508 |0 (DE-576)294122753 |4 aut | |
| 773 | 0 | 8 | |i In |t Breast cancer research and treatment |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1981 |g 150(2015), 1, Seite 127-139 |h Online-Ressource |w (DE-627)320433722 |w (DE-600)2004077-5 |w (DE-576)104194162 |x 1573-7217 |7 nnas |a Impact of body mass index on neoadjuvant treatment outcome a pooled analysis of eight prospective neoadjuvant breast cancer trials |
| 773 | 1 | 8 | |g volume:150 |g year:2015 |g number:1 |g pages:127-139 |g extent:13 |a Impact of body mass index on neoadjuvant treatment outcome a pooled analysis of eight prospective neoadjuvant breast cancer trials |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Impact of body mass index on neoadjuvant treatment outcome |d 2015 |w (DE-627)822031140 |w (DE-576)9822031149 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10549-015-3287-5 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s10549-015-3287-5 |x Verlag |3 Volltext |
| 856 | 4 | 0 | |u http://link.springer.com/article/10.1007/s10549-015-3287-5 |x Verlag |y Abstract |3 Volltext |
| 883 | |8 1\p |a cgwrk |d 20241001 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | ||
| 951 | |a AR | ||
| 992 | |a 20200824 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |e 910000PS109972554 |e 910400PS109972554 |k 0/910000/ |k 1/910000/910400/ |p 13 | ||
| 999 | |a KXP-PPN840616546 |e 374240945X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"name":{"displayForm":["Caterina Fontanella, Bianca Lederer, Stephan Gade, Mieke Vanoppen, Jens Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann, Bernd Gerber, Claus Hanusch, Jörn Hilfrich, Jens Huober, Andreas Schneeweiss, Stefan Paepke, Christian Jackisch, Keyur Mehta, Valentina Nekljudova, Michael Untch, Patrick Neven, Gunter von Minckwitz, Sibylle Loibl"]},"person":[{"display":"Fontanella, Caterina","given":"Caterina","family":"Fontanella","role":"aut"},{"given":"Bianca","display":"Lederer, Bianca","family":"Lederer","role":"aut"},{"given":"Stephan","display":"Gade, Stephan","role":"aut","family":"Gade"},{"given":"Mieke","display":"Vanoppen, Mieke","role":"aut","family":"Vanoppen"},{"given":"Jens-Uwe","display":"Blohmer, Jens-Uwe","family":"Blohmer","role":"aut"},{"role":"aut","family":"Costa","display":"Costa, Serban Dan","given":"Serban Dan"},{"given":"Carsten","display":"Denkert, Carsten","role":"aut","family":"Denkert"},{"family":"Eidtmann","role":"aut","given":"Holger","display":"Eidtmann, Holger"},{"role":"aut","family":"Gerber","display":"Gerber, Bernd","given":"Bernd"},{"display":"Hanusch, Claus Alexander","given":"Claus Alexander","role":"aut","family":"Hanusch"},{"display":"Hilfrich, Jörn","given":"Jörn","role":"aut","family":"Hilfrich"},{"display":"Huober, Jens","given":"Jens","family":"Huober","role":"aut"},{"given":"Andreas","display":"Schneeweiss, Andreas","family":"Schneeweiss","role":"aut"},{"given":"Stefan","display":"Paepke, Stefan","role":"aut","family":"Paepke"},{"given":"Christian","display":"Jackisch, Christian","role":"aut","family":"Jackisch"},{"display":"Mehta, Keyur","given":"Keyur","role":"aut","family":"Mehta"},{"role":"aut","family":"Nekljudova","display":"Nekljudova, Valentina","given":"Valentina"},{"given":"Michael","display":"Untch, Michael","family":"Untch","role":"aut"},{"family":"Neven","role":"aut","given":"Patrick","display":"Neven, Patrick"},{"given":"Gunter von","display":"Minckwitz, Gunter von","role":"aut","family":"Minckwitz"},{"given":"Sibylle","display":"Loibl, Sibylle","family":"Loibl","role":"aut"}],"recId":"840616546","title":[{"subtitle":"a pooled analysis of eight prospective neoadjuvant breast cancer trials","title":"Impact of body mass index on neoadjuvant treatment outcome","title_sort":"Impact of body mass index on neoadjuvant treatment outcome"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"13 S."}],"id":{"doi":["10.1007/s10549-015-3287-5"],"eki":["840616546"]},"relHost":[{"origin":[{"dateIssuedKey":"1981","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","publisher":"Springer Science + Business Media B.V. ; Kluwer","dateIssuedDisp":"1981-"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2004077-5"],"issn":["1573-7217"],"eki":["320433722"]},"title":[{"title":"Breast cancer research and treatment","title_sort":"Breast cancer research and treatment"}],"recId":"320433722","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Impact of body mass index on neoadjuvant treatment outcome a pooled analysis of eight prospective neoadjuvant breast cancer trialsBreast cancer research and treatment","pubHistory":["1.1981 -"],"note":["Gesehen am 02.12.05","Fortsetzung der Druck-Ausgabe"],"part":{"volume":"150","year":"2015","extent":"13","pages":"127-139","issue":"1","text":"150(2015), 1, Seite 127-139"},"language":["eng"]}],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"13 February 2015"}]} | ||
| SRT | |a FONTANELLAIMPACTOFBO1320 | ||